Following the sale of Pebble’s software soul to the devil this week (venture capitalists), Fitbit has given a sneak preview of how the new software-centric company could position itself in the future – kicking off by collaborating with medical industry players in mobile health (mHealth) projects. Fitbit has teamed up with medical technology firm Medtronic, in which it will synchronize exercise data from its dedicated user base with Medtronic’s iPro2 professional continuous glucose monitoring (CGM) system – providing a way for type 2 diabetics to monitor the positive effects of exercise on blood glucose levels using the myLog app. The data gathered can also be shared with healthcare providers, offering cost saving methods for the major health conglomerates, particularly public…